Serum anti-GM2 and anti-GalNAc-GD1a IgG antibodies are biomarkers for acute canine polyradiculoneuritis
by Angie Rupp and colleagues at the University of Glasgow
This study of a large geographically heterogenous cohort of dogs with acute canine polyradiculoneuritis (ACP) validated the use of anti-GM2 and anti-GalNAc-GD1a immunoglobulin G anti-glycolipid antibodies as serum biomarkers for ACP. Anti-GM2 AGAb measurement was identified as the most convenient single supportive biomarker for ACP.
Read more and access the publication
J of Small Animal Practice, Volume: 63, Issue: 2, Pages: 104-112, First published: 17 November 2021